Impact of CD14++CD16+ monocytes on plaque vulnerability in diabetic and non-diabetic patients with asymptomatic coronary artery disease: a cross-sectional study

Table 3 Monocyte subset counts and percentages

	Total N = 51	DM N = 22	Non-DM N = 29	p value DM vs. non-DM
Total monocyte, cell/μL	350.1 ± 180.3	355.9 ± 173.5	345.7 ± 188.1	0.84
CD14⁺⁺CD16⁻, cell/μL	233.0 ± 126.8	232.3 ± 115.6	233.6 ± 136.8	0.97
CD14⁺⁺CD16⁺, cell/μL	64.9 ± 47.4	65.5 ± 47.7	64.5 ± 48.0	0.94
CD14⁺CD16⁺⁺, cell/μL	52.1 ± 34.7	58.1 ± 38.0	47.6 ± 32.0	0.29
CD14⁺⁺CD16⁻, %	66.6 ± 12.4	66.5 ± 11.5	66.7 ± 13.2	0.95
CD14⁺⁺CD16⁺, %	18.2 ± 9.0	17.6 ± 6.7	18.7 ± 10.4	0.68
CD14⁺CD16⁺⁺, %	15.0 ± 6.1	15.8 ± 6.9	14.4 ± 5.4	0.44

ISSN: 1475-2840